Telomere and telomerase in stem cells

por Hiyama, E, Hiyama, K
Publicado 2007

Workshop on Prospect of Strangeness Nuclear Physics at J-PARC

por Outa, H, Nagae, Tomofumi, Hiyama, E
Publicado 2004

International Workshop on Strangeness Nuclear Physics (SNP12)

por Fukuda, T, Harada, T., Hiyama, E., Mizoi, Y., Motoba, T., Noumi, H.
Publicado 2013

Differential diagnosis of Th1/Th2-response by T-cell and monocyte function between sepsis and non-infectious SIRS via flowcytometry

por Imamura, Y, Yokoyama, T, Hiyama, E, Takesue, Y, Sueda, T, Zedler, S, Faist, E
Publicado 2001

MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening

por Iehara, T, Hosoi, H, Akazawa, K, Matsumoto, Y, Yamamoto, K, Suita, S, Tajiri, T, Kusafuka, T, Hiyama, E, Kaneko, M, Sasaki, F, Sugimoto, T, Sawada, T
Publicado 2006

Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma

por Honda, S, Arai, Y, Haruta, M, Sasaki, F, Ohira, M, Yamaoka, H, Horie, H, Nakagawara, A, Hiyama, E, Todo, S, Kaneko, Y
Publicado 2008

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the Int...

por Beiske, K, Burchill, S A, Cheung, I Y, Hiyama, E, Seeger, R C, Cohn, S L, Pearson, A D J, Matthay, K K
Publicado 2009

High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma

por Hiyama, E, Yamaoka, H, Matsunaga, T, Hayashi, Y, Ando, H, Suita, S, Horie, H, Kaneko, M, Sasaki, F, Hashizume, K, Nakagawara, A, Ohnuma, N, Yokoyama, T
Publicado 2004

Experience with International Neuroblastoma Staging System and Pathology Classification

por Ikeda, H, Iehara, T, Tsuchida, Y, Kaneko, M, Hata, J, Naito, H, Iwafuchi, M, Ohnuma, N, Mugishima, H, Toyoda, Y, Hamazaki, M, Mimaya, J, Kondo, S, Kawa, K, Okada, A, Hiyama, E, Suita, S, Takamatsu, H
Publicado 2002